Cancer genomics identifies disrupted epigenetic genes

Area of Science:

• Genomics
• Cancer Biology
• Epigenetics

Background:

• Epigenetic gene alterations are increasingly discovered in cancer.
• Early research focused on single genes, but epigenomic platforms accelerate discovery.
• Translational applications in cancer epigenomics are advancing.

Purpose of the Study:

• To provide an overview of the evolution of cancer epigenomics.
• To present an updated catalog of epigenetic pathway disruptions in cancer.
• To facilitate the translation of epigenomic discoveries to clinical practice.

Main Methods:

• Review of epigenetic gene discovery and epigenomic platform evolution.
• Compilation of a catalog of epigenetic pathway disruptions.
• Analysis of mutations in cell lines and primary tumors.

Main Results:

• Significant advances in identifying cancer-associated epigenetic genes.
• Development of epigenomic platforms has accelerated research.
• A catalog of key epigenetic disruptions in cancer is established.

Conclusions:

• Understanding cancer epigenomics is crucial for developing new diagnostics and therapies.
• The catalog of epigenetic alterations provides a foundation for clinical translation.
• Future research will focus on moving epigenomic insights from the bench to the bedside.